| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,718 |
7,314 |
$956K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,286 |
3,370 |
$534K |
| 36415 |
Collection of venous blood by venipuncture |
4,406 |
3,629 |
$197K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
649 |
545 |
$196K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,926 |
1,738 |
$112K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,531 |
1,558 |
$100K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,627 |
3,144 |
$79K |
| 80053 |
Comprehensive metabolic panel |
1,679 |
1,462 |
$70K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,277 |
1,097 |
$58K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
964 |
861 |
$57K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
275 |
240 |
$51K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
311 |
259 |
$26K |
| 83735 |
|
1,075 |
948 |
$19K |
| 86140 |
|
727 |
637 |
$18K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
410 |
345 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
645 |
546 |
$18K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
343 |
178 |
$16K |
| 71045 |
Radiologic examination, chest; single view |
266 |
242 |
$13K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
96 |
27 |
$12K |
| 84484 |
|
224 |
181 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
292 |
268 |
$10K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
137 |
121 |
$9K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
37 |
35 |
$8K |
| 81003 |
|
508 |
445 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
179 |
150 |
$6K |
| 84145 |
|
69 |
66 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
290 |
248 |
$3K |
| 87634 |
|
58 |
46 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
92 |
87 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
46 |
41 |
$3K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
370 |
330 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
61 |
54 |
$3K |
| 85027 |
|
150 |
133 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
38 |
36 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
14 |
13 |
$2K |
| 91301 |
|
42 |
39 |
$2K |
| 83605 |
|
52 |
49 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
165 |
151 |
$1K |
| 81001 |
|
105 |
94 |
$1K |
| 85379 |
|
12 |
12 |
$603.07 |
| 83690 |
|
45 |
42 |
$566.22 |
| Q3014 |
Telehealth originating site facility fee |
19 |
12 |
$332.37 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
12 |
$251.38 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16 |
12 |
$234.06 |
| 74018 |
|
13 |
13 |
$225.54 |
| 0011A |
|
22 |
21 |
$218.49 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$199.00 |
| 90686 |
|
23 |
14 |
$194.10 |
| 0012A |
|
16 |
16 |
$189.64 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
16 |
14 |
$82.00 |
| 90656 |
|
14 |
14 |
$75.91 |
| 85610 |
|
21 |
12 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
184 |
156 |
$0.00 |